• Zhi-Yong Xu, Shi-Xiong Liang, Ji Zhu, Xiao-Dong Zhu, Jian-Dong Zhao, Hai-Jie Lu, Yun-Li Yang, Long Chen, An-Yu Wang, Xiao-Long Fu, and Guo-Liang Jiang.
• Department of Radiation Oncology, Fudan University Cancer Hospital, Shanghai, China.
• Int. J. Radiat. Oncol. Biol. Phys. 2006 May 1; 65 (1): 189-95.

PurposeTo describe the probability of RILD by application of the Lyman-Kutcher-Burman normal-tissue complication (NTCP) model for primary liver carcinoma (PLC) treated with hypofractionated three-dimensional conformal radiotherapy (3D-CRT).Methods And MaterialsA total of 109 PLC patients treated by 3D-CRT were followed for RILD. Of these patients, 93 were in liver cirrhosis of Child-Pugh Grade A, and 16 were in Child-Pugh Grade B. The Michigan NTCP model was used to predict the probability of RILD, and then the modified Lyman NTCP model was generated for Child-Pugh A and Child-Pugh B patients by maximum-likelihood analysis.ResultsOf all patients, 17 developed RILD in which 8 were of Child-Pugh Grade A, and 9 were of Child-Pugh Grade B. The prediction of RILD by the Michigan model was underestimated for PLC patients. The modified n, m, TD50 (1) were 1.1, 0.28, and 40.5 Gy and 0.7, 0.43, and 23 Gy for patients with Child-Pugh A and B, respectively, which yielded better estimations of RILD probability. The hepatic tolerable doses (TD5) would be MDTNL of 21 Gy and 6 Gy, respectively, for Child-Pugh A and B patients.ConclusionsThe Michigan model was probably not fit to predict RILD in PLC patients. A modified Lyman NTCP model for RILD was recommended.

28 keywords...

hide…